References

Atopic dermatitis

10.1016/s0140-6736(20)31286-1 · 2020 · External reference

Atopic dermatitis

10.1038/s41572-018-0001-z · 2018 · External reference

10.1111/j.1365-2222.2007.02679.x

10.1111/j.1365-2222.2007.02679.x · External reference

10.1111/bjd.14167

10.1111/bjd.14167 · External reference

Epidemiology of adult atopic dermatitis

10.1016/j.clindermatol.2018.05.007 · 2018 · External reference

10.1111/j.1346-8138.2006.00187.x

10.1111/j.1346-8138.2006.00187.x · External reference

Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study

10.1016/j.anai.2018.07.006 · 2018 · External reference

10.1016/j.jid.2016.07.012

10.1016/j.jid.2016.07.012 · External reference

10.1111/bjd.19580

10.1111/bjd.19580 · External reference

10.1016/j.jaad.2023.08.102

10.1016/j.jaad.2023.08.102 · External reference

Dupilumab: First Global Approval

10.1007/s40265-017-0768-3 · 2017 · External reference

Tralokinumab: First Approval

10.1007/s40265-021-01583-1 · 2021 · External reference

Nemolizumab: First Approval

10.1007/s40265-022-01741-z · 2022 · External reference

Lebrikizumab: First Approval

10.1007/s40265-024-02000-z · 2024 · External reference

Stapokibart: First Approval

10.1007/s40265-025-02151-7 · 2025 · External reference

Abrocitinib: First Approval

10.1007/s40265-021-01638-3 · 2021 · External reference

10.3310/plrq4216

10.3310/plrq4216 · External reference

European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

10.1111/jdv.18345 · 2022 · External reference

Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis Update

10.1001/jamadermatol.2024.2192 · 2024 · External reference

10.1002/psp4.12041

10.1002/psp4.12041 · External reference

10.1136/bjsports-2023-107625

10.1136/bjsports-2023-107625 · External reference

Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis

10.1002/cpt.732 · 2017 · External reference

A model-based quantitative analysis of efficacy and associated factors of platelet rich plasma treatment for osteoarthritis

10.1097/js9.0000000000000337 · 2023 · External reference

Quantitative analysis of the efficacy and associated factors of intra-articular hyaluronic acid with respect to osteoarthritis symptoms: A systematic review of randomized trials and model-based meta-analysis

10.1016/j.joca.2025.01.008 · 2025 · External reference

10.1038/s41573-021-00266-6

10.1038/s41573-021-00266-6 · External reference

Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis

10.1001/jamadermatol.2020.0796 · 2020 · External reference

Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis

10.1001/jamadermatol.2022.0455 · 2022 · External reference

Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis

10.1093/bjd/ljad393 · 2024 · External reference

Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis

10.1093/bjd/ljaf166 · 2025 · External reference

The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

10.1136/bmj.d5928 · 2011 · External reference

Placebo Response to Oral Administration in Osteoarthritis Clinical Trials and Its Associated Factors: A Model-Based Meta-analysis

10.1001/jamanetworkopen.2022.35060 · 2022 · External reference

Model-Based Meta-Analysis in Ankylosing Spondylitis: A Quantitative Comparison of Biologics and Small Targeted Molecules

10.1002/cpt.1305 · 2019 · External reference

Testing whether the progression of Alzheimer’s disease changes with the year of publication, additional design, and geographical area: a modeling analysis of literature aggregate data

10.1186/s13195-020-00630-5 · 2020 · External reference

Quantitative analysis of the placebo response in pharmacotherapy of insomnia and its application in clinical trials

10.1093/sleep/zsz286 · 2020 · External reference

Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs

10.1111/all.16009 · 2024 · External reference

Emerging Biologic Therapies for the Treatment of Atopic Dermatitis

10.1007/s40265-024-02095-4 · 2024 · External reference

Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules

10.3389/fphar.2021.586827 · 2021 · External reference